The Efficacy of Platelets Rich Plasma for Ovarian Rejuvenation
Sponsored by Al-Kindy College of Medicine
About this trial
Last updated 3 years ago
Study ID
12 Al-KindyCM
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
20 to 49 Years
Female
Not accepting
Healthy Volunteers
Trial Timing
Ended 7 years ago
What is this trial about?
In recent years, an increased approach has appeared in the use of autologous blood products to assist tissue and organ healing. Application of platelet rich plasma (PRP) has emerged as a potential solution for infertile women with poor ovarian reserve in reproductive specialty.
What are the participation requirements?
Inclusion Criteria
1. Menopause or peri-menopause under the age of 50.
2. Premature ovarian insufficiency which is ovarian failure before the age of 40.
3. Woman with primary ovarian failure of any cause.
Exclusion Criteria
1. A previous injection with any medication, plasma, or PRP
2. Invisible or difficult access ovaries.
3. Medical disease or unfit for anesthesia patient.